Effects of Opioids, Benzodiazepines, Gabapentinoids, and Antidepressants on Fracture Risk in Alcohol‐Related Cirrhosis
Liver International · 2026
DOI: 10.1111/liv.70667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Frederik Kraglund und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Antidepressive Agents, Benzodiazepines, Analgesics, Opioid, Liver Cirrhosis, Alcoholic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden.
Abstract (Originalsprache)
Background
Patients with alcohol‐related liver cirrhosis (ALD cirrhosis) have an increased risk of falls and fractures. Opioids, benzodiazepines, gabapentinoids, and antidepressants are known to increase fall risk.
Aims
We aimed to determine the effects of opioids, benzodiazepines, gabapentinoids, and antidepressants on fracture risk in ALD cirrhosis.
Methods
Using Danish nationwide registries, we identified all patients diagnosed with ALD cirrhosis in 2000–2023 and their subsequent hospitalisations for fracture. Redeemed prescriptions defined exposure to opioids, benzodiazepines, gabapentinoids, and antidepressants. We applied Cox and Poisson regression to estimate fracture risks with and without exposure, adjusting for confounders. To minimise confounding, we also used a self‐controlled case‐crossover design.
Results
Among 24 743 patients with newly diagnosed ALD cirrhosis, the 5‐year fracture risk was 19.0% (95% CI: 18.4%–19.4%). Fracture risk was increased during the first 30 days after initiation of opioids (adjusted hazard ratio [aHR]: 3.20, 95% CI: 2.30–4.45), benzodiazepines (aHR: 2.17, 95% CI: 1.37–3.76), or gabapentinoids (aHR: 2.43, 95% CI: 1.66–3.55), whereas antidepressant initiation did not affect fracture risk (aHR: 1.07, 95% CI: 0.62–1.84). Similar within‐person results were obtained using the self‐controlled design. Notably, the risk‐increasing effects of opioids, benzodiazepines, and gabapentinoids decreased with the duration of exposure, and none of the drugs increased fracture risk if the patient had been using them for more than 365 days.
Conclusions
In ALD cirrhosis, fracture risk is increased when treatment with opioids, benzodiazepines, or gabapentinoids is initiated, but not with long‐term use. Precautionary measures are recommended when initiation of these drugs is indicated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Biomedicine, Health, Aarhus University, Aarhus, Denmark.
- Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
- School of Medicine, University of Nottingham, Nottingham, UK.
ORCID-Profile: Frederik Kraglund
Förderung
- Novo Nordisk Fonden
Zitieren
APA
Kraglund, F., Deleuran, T., Storgaard, M. A., Sædder, E., & Jepsen, P. (2026). Effects of Opioids, Benzodiazepines, Gabapentinoids, and Antidepressants on Fracture Risk in Alcohol‐Related Cirrhosis. Liver International. https://doi.org/10.1111/liv.70667
Vancouver
Kraglund F, Deleuran T, Storgaard MA, Sædder E, Jepsen P. Effects of Opioids, Benzodiazepines, Gabapentinoids, and Antidepressants on Fracture Risk in Alcohol‐Related Cirrhosis. Liver International. 2026. doi:10.1111/liv.70667
BibTeX
@article{Kraglund2026,
author = {Kraglund, Frederik and Deleuran, Thomas and Storgaard, Marie Aarup and Sædder, Eva and Jepsen, Peter},
title = {Effects of Opioids, Benzodiazepines, Gabapentinoids, and Antidepressants on Fracture Risk in Alcohol‐Related Cirrhosis},
journal = {Liver International},
year = {2026},
doi = {10.1111/liv.70667}
}
EUVIMED